Globally, women are affected by HIV accounting for nearly half of HIV infections worldwide and almost two-thirds of those among young people, with female infections rising in almost every region. Yet twenty-five years into the global AIDS epidemic, there is still no widely available technology that women can both initiate and control to protect themselves from HIV. Given the AIDS epidemic’s disproportionate impact on women, there is a critical need to develop prevention options that women can use with, or when necessary without, their partner's active cooperation.
This Town Hall meeting will introduce participants to the spectrum of female-initiated HIV-prevention options for women, status of the latest clinical research, emphasize the importance of working with the community of women living with HIV/AIDS, and equip participants to return to their communities with action agendas.

Sponsor : Aids Vaccine Advocacy Coalition (AVAC); African Microbicides; Advocacy Group (AMAG); Global Campaign For Microbicides (GCM); Ibis Reproductive Health; International Aids Vaccine Initiative (LAVI); International Partnership For Microbicides (OPM); Population Council; United Nations Population Fund (UNFPA); Nairobi Pentecostal Church; Kenya YWCA; World YWCA.